Abstract
Protease-activated receptor 2 (PAR-2) has been implicated in the regulation of several cellular functions in the progression of cancer. It is reported that PAR-2 expression is significantly increased in human renal cell carcinoma (RCC) tissue compared with the adjacent non-neoplastic kidney tissue. However, the function of PAR-2 in regulating cell invasion and migration of RCC remains elusive. In this study, we found that PAR-2 was overexpressed in RCC cells. Activation of PAR-2 with PAR-2AP (PAR-2 agonist) enhanced the invasion and migration of RCC cells, and increased the expressions of MMP-13 and urokinase plasminogen activator (uPA). However, knockdown of PAR-2 by siRNA could intervene in all regulating effects of PAR-2AP. Furthermore, activation of PAR-2 induced the activation of PI3K and AKT, and PI3K/AKT inhibitor LY294002 attenuated the invasion and migration of RCC cells stimulated by PAR-2 activation. Altogether, our study demonstrates that PAR-2 stimulates the activation of PI3K/AKT pathway, subsequently increasing the expressions of MMP-13 and uPA, and thereby promotes the invasion and migration of RCC cells.
References
Jan 21, 2006·Journal of Surgical Oncology·Daisuke FujimotoAkio Yamaguchi
Jul 4, 2006·The American Journal of Pathology·Roberta CarusoGiovanni Monteleone
Mar 22, 2007·The Prostate·Peter C BlackThomas K Takayama
Oct 16, 2008·Biochemical and Biophysical Research Communications·Yusuke TanakaAtsufumi Kawabata
Oct 22, 2008·BMC Cancer·Israt JahanTeruhiko Tamaya
Jun 12, 2009·The Journal of Investigative Dermatology·Paola ZigrinoCornelia Mauch
Jul 16, 2010·Diseases of the Colon and Rectum·Jae Hyuck ChangSeong Taek Oh
Aug 26, 2010·Blood·Troy A McEachronNigel Mackman
Oct 12, 2010·The Journal of International Medical Research·X WangY L Zheng
Dec 15, 2010·Oncology Reports·Baocheng ZhouYing Wu
Oct 14, 2011·The Journal of Investigative Dermatology·Cordula KempkesMartin Steinhoff
Apr 14, 2012·Biochemical and Biophysical Research Communications·Angélica Dutra-OliveiraAndréa Mariano-Oliveira
Sep 4, 2012·Oncology Reports·Liqun XieFei Li
Sep 4, 2012·Oncology Reports·Cheng ZhangXue-Feng Zhang
Sep 11, 2012·Experimental and Molecular Pathology·Xiaotun ZhangRobert L Vessella
Dec 4, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Linlin Tang, Xiuzhen Han
May 18, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Elin Hadler-OlsenLars Uhlin-Hansen
Oct 22, 2013·Cancer Investigation·Shao-hong HuangSheng Ye
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jan 29, 2014·Oncogene·K U SalesT H Bugge
Citations
Aug 10, 2016·Journal of Cellular Biochemistry·LeCheng WuBin Ni
Mar 3, 2018·International Journal of Molecular Sciences·Anna Klimaszewska-WiśniewskaDariusz Grzanka
Jun 20, 2019·Bioscience Reports·Kai-Liang TangShi-Jiang Xiong
Mar 22, 2018·Oncotarget·Pengming SunJalid Sehouli
May 4, 2018·Oncotarget·Tobias EnglRoman A Blaheta
Sep 30, 2020·Archives of Physiology and Biochemistry·Xiaojuan WangYu Ning
Sep 19, 2020·Cell Death & Disease·Wentian ZhangHecheng Li
Oct 31, 2020·Medicine·Marinel Ocasio-RiveraEdu Suarez-Martínez
Dec 29, 2020·Frontiers in Oncology·Charlotte Nicole HillGareth I Owen
Mar 26, 2021·PloS One·Christudas MoraisDavid A Vesey